AU1751488A - The use of polyvinylpyrrolidone (pvp) to reduce the turbidity of sera, sera containing pvp, and a process for the preparation thereof - Google Patents

The use of polyvinylpyrrolidone (pvp) to reduce the turbidity of sera, sera containing pvp, and a process for the preparation thereof

Info

Publication number
AU1751488A
AU1751488A AU17514/88A AU1751488A AU1751488A AU 1751488 A AU1751488 A AU 1751488A AU 17514/88 A AU17514/88 A AU 17514/88A AU 1751488 A AU1751488 A AU 1751488A AU 1751488 A AU1751488 A AU 1751488A
Authority
AU
Australia
Prior art keywords
pvp
sera
polyvinylpyrrolidone
turbidity
reduce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU17514/88A
Other versions
AU606705B2 (en
Inventor
Dagmar Steuer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Publication of AU1751488A publication Critical patent/AU1751488A/en
Application granted granted Critical
Publication of AU606705B2 publication Critical patent/AU606705B2/en
Assigned to DADE BEHRING MARBURG GMBH reassignment DADE BEHRING MARBURG GMBH Request to Amend Deed and Register Assignors: BEHRINGWERKE AKTIENGESELLSCHAFT
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/25—Reference solutions for assays of biological material containing added polymers to stabilise biological material against degradation or maintain viscosity or density, e.g. gelatin, polyacrylamides or polyvinyl alcohol
    • G01N2496/35—Polyvinylpyrrolidone, e.g. PVP
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Artificial Filaments (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • External Artificial Organs (AREA)
  • Detergent Compositions (AREA)

Abstract

Polyvinylpyrrolidone is used to reduce turbidity in a dried and reconstituted human- and animal-based serum, which may contain metered lipids.
AU17514/88A 1987-06-09 1988-06-08 The use of polyvinylpyrrolidone (pvp) to reduce the turbidity of sera, sera containing pvp, and a process for the preparation thereof Ceased AU606705B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873719196 DE3719196A1 (en) 1987-06-09 1987-06-09 USE OF POLYINYLPYRROLIDONE (PVP) FOR REDUCING THE TURBIDITY OF SERES, CONTROLLING SERIES CONTAINING PVP AND METHOD FOR THE PRODUCTION THEREOF
DE3719196 1987-06-09

Publications (2)

Publication Number Publication Date
AU1751488A true AU1751488A (en) 1988-12-15
AU606705B2 AU606705B2 (en) 1991-02-14

Family

ID=6329317

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17514/88A Ceased AU606705B2 (en) 1987-06-09 1988-06-08 The use of polyvinylpyrrolidone (pvp) to reduce the turbidity of sera, sera containing pvp, and a process for the preparation thereof

Country Status (6)

Country Link
EP (1) EP0294714B1 (en)
JP (1) JP2604005B2 (en)
AT (1) ATE78604T1 (en)
AU (1) AU606705B2 (en)
CA (1) CA1306679C (en)
DE (2) DE3719196A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3719196A1 (en) * 1987-06-09 1988-12-29 Behringwerke Ag USE OF POLYINYLPYRROLIDONE (PVP) FOR REDUCING THE TURBIDITY OF SERES, CONTROLLING SERIES CONTAINING PVP AND METHOD FOR THE PRODUCTION THEREOF
DE4344868A1 (en) * 1993-12-29 1995-08-03 Behringwerke Ag Process for the preparation of long-term stable clear sera
DE19850074A1 (en) * 1998-10-30 2000-05-04 Dade Behring Marburg Gmbh Stabilization of biological liquids by adding sterol esters
CN103472240B (en) * 2013-08-23 2016-03-23 上海北加生化试剂有限公司 People's blood fat (serum/plasma) quality management reference kit and preparation method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1930059C3 (en) * 1969-06-13 1975-11-13 Boehringer Mannheim Gmbh Stabilized nicotinamide adenine dinucleotide or or and nicotinamide adenine dinucleotide phosphate
JPS5465095A (en) * 1977-11-02 1979-05-25 Toa Medical Electronics Diluted liquid for counting blood platelets
US4215993A (en) * 1978-12-04 1980-08-05 Data Medical Associates, Inc. Precipitating reagent and method for isolation and determination of high density lipoproteins in human serum
DE2904305C2 (en) * 1979-02-05 1981-07-02 Boehringer Mannheim Gmbh, 6800 Mannheim Lipase determination reagent and process for its preparation
DE3329952A1 (en) * 1983-08-19 1985-02-28 Behringwerke Ag, 3550 Marburg METHOD FOR REDUCING TURBIDITY IN CONTROL SERIES
DE3719196A1 (en) * 1987-06-09 1988-12-29 Behringwerke Ag USE OF POLYINYLPYRROLIDONE (PVP) FOR REDUCING THE TURBIDITY OF SERES, CONTROLLING SERIES CONTAINING PVP AND METHOD FOR THE PRODUCTION THEREOF
FR2623628B1 (en) * 1987-11-20 1990-04-20 Bio France Reactifs STANDARD SERUM, HUMAN IN NATURE, RECONSTITUTED FROM REJECTED FRACTIONS (NOT USED IN THERAPEUTICS), FRACTIONATION OF HUMAN PLASMA, HUMAN BLOOD, PLACENTAL OR RETROPLACENT BLOOD

Also Published As

Publication number Publication date
CA1306679C (en) 1992-08-25
AU606705B2 (en) 1991-02-14
EP0294714B1 (en) 1992-07-22
JPS63315947A (en) 1988-12-23
JP2604005B2 (en) 1997-04-23
EP0294714A3 (en) 1989-03-22
EP0294714A2 (en) 1988-12-14
ATE78604T1 (en) 1992-08-15
DE3719196A1 (en) 1988-12-29
DE3872952D1 (en) 1992-08-27

Similar Documents

Publication Publication Date Title
EP0200412A3 (en) Method of conferring immunotolerance to a specific antigen
AU535040B2 (en) Stable protein solutions
SE8206168D0 (en) PREPARATIONS AND PROCESS FOR PREPARATION THEREOF
EP0209061A3 (en) Peptides having an anticoagulant activity, process for their preparation, obtention, their use and agents containing them
ZA888170B (en) Enzyme immunoassay for detecting hiv antigens in human sera
FR2569599B1 (en) APPARATUS FOR POLISHING SLICES OF FLAT OBJECTS, ESPECIALLY GLASS
AU2470288A (en) Acid gas absorbent composition
JPS6485086A (en) Protein f for outer membrane of pseudomonas aeruginosa
AU1130688A (en) Reagent and procedure for determining cations
AU8188087A (en) Variants of hirudin, their use and their preparation
AU1751488A (en) The use of polyvinylpyrrolidone (pvp) to reduce the turbidity of sera, sera containing pvp, and a process for the preparation thereof
AU2687188A (en) New derivatives of cyclic amino acids, a process for the preparation thereof, agents containing them, and the use thereof
GB2071656B (en) 7-ozo-1-azabicyclo(3,2,0)hept-2-ene-2-carboxylic acid derivatives their use and preparation
AU6650086A (en) Process for preparation of synthetic faujasite molded body
AU7688287A (en) Baby rocker
AU616667B2 (en) Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use
IE831482L (en) Stabilizing memadione and thiamine
EP0337466A3 (en) Process for determinating the thyroxin binding capacity and standard solution therefor
AU1616488A (en) Protein absorption enhancing agents
AU2741788A (en) Measurement of transferrin
ZA892702B (en) Process for the determination of thyroxine and a suitable standard solution therefor
JPS6438657A (en) Solid phase antibody for immunoassay
IL86277A0 (en) Process for the preparation of foreign proteins in streptomycetes
JPS5694267A (en) Highly coagulating*active antibody serum
JPS6438658A (en) Solid phase antibody for immunoassay

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired